Business: Pharmaceutical

Acadia 3Q loss narrows on revenue boost

AP - Mon Nov 9, 6:26 PM ET

SAN DIEGO - Acadia Pharmaceuticals Inc. said Monday its third-quarter loss narrowed on lower costs and a boost in revenue from its drug development partners.

  • A sign for Pharmaceutical company Pfizer is displayed on 42 Street in New York, seen here in October 2009. Pfizer announced Monday cuts in its research activities and staff after acquiring pharmaceutical rival Wyeth.(AFP/File/Timothy A. Clary)
    Pfizer slashes research, staff after Wyeth deal AFP - Mon Nov 9, 1:50 PM ET

    NEW YORK (AFP) - Pfizer announced Monday cuts in its research activities and staff after acquiring pharmaceutical rival Wyeth.

  • Enzon sells specialty drug business for $300M AP - Mon Nov 9, 11:18 AM ET

    BRIDGEWATER, N.J. - Enzon Pharmaceuticals Inc. said Monday it is selling most of its business to Italian drugmaker sigma-tau Group and will focus on its experimental cancer drugs and technologies.

  • Customers outside an Apotek Renen drug store in central Stockholm. Sweden sold 465 of its estimated 900 state-owned pharmacies to four firms for 5.9 billion kronor (572 million euros, 856 million dollars), authorities said Monday, ending a 36-year-old monopoly.(AFP/SCANPIX/File/Leif R Jansson)
    Auction ends Swedish pharmacy monopoly AFP - Mon Nov 9, 11:01 AM ET

    STOCKHOLM (AFP) - Sweden sold 465 of its estimated 900 state-owned pharmacies to four firms for 5.9 billion kronor (572 million euros, 856 million dollars), authorities said Monday, ending a 36-year-old monopoly.

  • Halozyme takes bigger loss on testing expenses AP - Fri Nov 6, 11:21 AM ET

    SAN DIEGO - Biotechnology company Halozyme Therapeutics Inc. reported a bigger third-quarter loss on Friday, as it started clinical trials of a fast-acting insulin during the period.

  • Threshold Pharmaceuticals 3Q loss widens on costs AP - Fri Nov 6, 10:43 AM ET

    REDWOOD CITY, Calif. - Threshold Pharmaceuticals Inc., a development-stage biotechnology company, said late Thursday its third-quarter loss widened on higher research, development, and interest expenses.

  • In this Feb. 11, 2009 image rendered from video and provided by WHDH-TV in Boston, Tarek Mehanna is seen outside the federal court in Boston. Federal authorities in Boston said Wednesday, Oct. 21, 2009, that Mehanna has been charged with conspiring with others on terror attacks against shoppers in U.S. malls and against U.S. military in Iraq. (AP Photo/WHDH-TV)
    Mass. man faces new charges in alleged terror plot AP - Thu Nov 5, 10:01 PM ET

    BOSTON - A pharmacy college graduate was indicted Thursday on new charges in an alleged terror plot to kill two prominent U.S. politicians and shoot people at American shopping malls.

  • On the Call: Cigna President David Cordani AP - Thu Nov 5, 4:51 PM ET

    Health insurer WellPoint Inc. announced plans last spring to sell its pharmacy benefits management business to Express Scripts Inc. for about $4.68 billion. Analysts have wondered whether other managed care companies would consider a similar sale.

  • In this Nov. 3, 2009 photo, a CVS pharmacy sign is seen opposite the interior of one of the CVS locations, in Providence, R.I. CVS Caremark Corp. said Thursday, Nov. 5, 2009, its third-quarter profit jumped 39 percent on a boost from pharmacy benefits services and drugstore sales. (AP Photo/Steven Senne)
    CVS Caremark 3Q profit up but loses big contracts AP - Thu Nov 5, 4:49 PM ET

    NEW YORK - CVS Caremark disclosed more multibillion dollar contract losses in its pharmacy benefits management business and said the head of the unit will depart.

  • King 3Q profit falls on charges, but tops forecast AP - Thu Nov 5, 10:43 AM ET

    BRISTOL, Tenn. - Drug developer King Pharmaceuticals said Thursday its third-quarter profit was cut in half by charges for related to its $1.6 billion buyout of rival Alpharma Inc.

  • BioCryst receives $22.5 million peramivir order AP - Thu Nov 5, 8:55 AM ET

    BIRMINGHAM, Ala. - BioCryst Pharmaceuticals Inc. said Thursday it will receive $22.5 million as part of a new contract with the Department of Health and Human Services over the intravenous flu treatment peramivir.

  • Acne, wrinkle treatments help Medicis post profit AP - Wed Nov 4, 6:21 PM ET

    SCOTTSDALE, Ariz. - Medicis Pharmaceutical Corp. posted a third-quarter profit on Wednesday, as sales of its skin products surged, and a research and development charge came off the books.

  • BioCryst partner seeks peramivir approval in Japan AP - Wed Nov 4, 1:49 PM ET

    BIRMINGHAM, Ala. - BioCryst Pharmaceuticals Inc. said Wednesday its partner Shionogi & Co. filed for approval to market BioCryst's IV flu drug peramivir in Japan.

  • Affymax 3Q loss narrows partnership payments AP - Wed Nov 4, 10:18 AM ET

    PALO ALTO, Calif. - Biotechnology company Affymax Inc. said Wednesday its third-quarter loss narrowed on a boost in payments from its partner Takeda Pharmaceutical on the anemia drug candidate Hematide.

  • Watson 3Q profit falls 11 percent on taxes, costs AP - Wed Nov 4, 9:50 AM ET

    MORRISTOWN, N.J. - Drug developer Watson Pharmaceuticals Inc. said Wednesday its profit fell 11 percent in the third quarter as higher taxes and charges offset a revenue boost.

  • A car enters the employee entrace at the headquarters for drug maker Merck in Kenilworth, New Jersey. US pharmaceutical giant Merck & Co. finalized its acquisition of rival Schering-Plough on Tuesday, a 41-billion-dollar deal creating the number two firm in the sector.(AFP/Getty Images/File/Chris Hondros)
    Merck completes acquisition of Schering-Plough AFP - Tue Nov 3, 4:55 PM ET

    WASHINGTON (AFP) - US pharmaceutical giant Merck & Co. finalized its acquisition of rival Schering-Plough on Tuesday, a 41-billion-dollar deal creating the number two firm in the sector.

  • Medco Health 3Q profit jumps 13.5 percent AP - Tue Nov 3, 1:29 PM ET

    NEW YORK - Medco Health Solutions Inc., the largest U.S. pharmacy benefits manager, said Tuesday its profit rose 13.5 percent as the company gained new clients and benefited from price inflation of brand-name drugs.

  • A nurse gives a shot of the H1N1 vaccine to Mandi Russell, who is seven and a half months pregnant, at the Utah County Health Department in October 2009 in Provo, Utah. A single dose of swine flu vaccine produces a robust immune response in pregnant women, one of the groups at higher risk of dying from (A)H1N1 influenza, initial results from US clinical trials have shown.(AFP/Getty Images/File/George Frey)
    One swine flu shot enough for pregnant women, two for kids AFP - Tue Nov 3, 11:35 AM ET

    WASHINGTON (AFP) - A single dose of swine flu vaccine produces a robust immune response in pregnant women, one of the groups at high risk of dying from (A)H1N1 influenza, but young children need two shots, US clinical trials have shown.

  • J&J to slash 7,000 to 8,000 jobs Reuters - Tue Nov 3, 2:06 PM ET

    NEW YORK (Reuters) - Johnson & Johnson plans to cut up to 7 percent of its workforce in order to generate cost savings needed to finance increasingly costly drug research and to weather future challenges, the diversified healthcare company said on Tuesday.

  • Swiss pharmaceuticals giant Novartis headquarters in Basel. Swiss pharmaceutical group Novartis said that it would invest 1.0 billion dollars (680 million euros) in research and development in China to latch on to growing demand for health care.(AFP/File/Sebastien Bozon)
    Novartis to invest billion dollars in China AFP - Tue Nov 3, 5:13 AM ET

    GENEVA (AFP) - Swiss pharmaceutical group Novartis said Tuesday that it would invest 1.0 billion dollars (680 million euros) in research and development in China to latch on to growing demand for health care.

  • New damages trial for Wyeth in Ark. hormones case AP - Mon Nov 2, 7:21 PM ET

    LITTLE ROCK, Ark. - Wyeth Pharmaceuticals will get a new trial to determine if the drugmaker should pay punitive damages to a woman who got breast cancer after taking hormone replacement therapy, a federal appeals court ruled Monday.

  • Amylin signs weight-loss drug deal with Takeda AP - Mon Nov 2, 5:30 PM ET

    NEW YORK - Amylin Pharmaceuticals Inc. says it could potentially receive more than $1 billion from a partnership with Japan's Takeda Pharmaceutical Co. on potential weight-loss treatments.

  • Earnings Preview: Medco Health Solutions AP - Mon Nov 2, 12:20 PM ET

    NEW YORK - Medco Health Solutions Inc., the largest U.S. pharmacy benefits manager, is scheduled to report its third-quarter results Tuesday morning. The following is a summary of key developments and analyst commentary for the period.

  • Valeant 3Q net income down, results top forecast AP - Mon Nov 2, 10:47 AM ET

    ALISO VIEJO, Calif. - Valeant Pharmaceuticals International said Monday its third-quarter net income plunged, a year after selling businesses in Europe, Africa, and the Middle East, but adjusted profit topped Wall Street expectations.

  • Exelixis shares rise on 3Q results AP - Fri Oct 30, 12:04 PM ET

    NEW YORK - Shares of biotechnology company Exelixis Inc. rose Friday after the company narrowed its profit loss on a surge in revenue from partnerships with several large pharmaceutical companies.

  • Lawyer in landmark breast implant lawsuits dies AP - Fri Oct 30, 9:14 AM ET

    HOUSTON - Flamboyant lawyer John O'Quinn, who won billions in verdicts against makers of breast implants, pharmaceuticals and tobacco products, died Thursday in a traffic wreck. He was 68.

  • PerkinElmer profit tumbles on lower sales AP - Thu Oct 29, 7:05 PM ET

    WALTHAM, Mass. - PerkinElmer Inc., which supplies equipment and services to pharmaceutical and other companies, says third-quarter profit and sales fell, but the CEO said he was seeing encouraging signs.

  • Phase Forward posts 3rd-quarter profit decline AP - Thu Oct 29, 6:17 PM ET

    WALTHAM, Mass. - Phase Forward Inc., a provider of data management software for drug safety and clinical trials, reported its third-quarter profit sank nearly 50 percent, but still handily beat Wall Street's forecast.

  • Hundreds arrested in Ky. prescription crackdown AP - Thu Oct 29, 7:42 PM ET

    LEXINGTON, Ky. - More than 300 people were arrested and 200 more targeted in a crackdown on a multi-state prescription pill pipeline, a bust that Kentucky officials said Thursday was the largest in the state's history.

  • Study: Cholesterol drugs may improve flu survival AP - Thu Oct 29, 3:29 PM ET

    Doctors may have a new treatment for swine flu that's already on pharmacy shelves — cholesterol-lowering statin drugs like Pfizer's Lipitor and Zocor.

1  2  3    Next